Keywords
Cognitive Deficit
Metabolic Syndrome
MMSE
How to Cite
Copyright © | All rights reserved.
The journal holds the exclusive copyright for the publication of this article under the terms of Brazilian law 9610/98.
Partial reproduction
The use of parts of the texts, figures and questionnaire of the article is free, being mandatory the citation of the authors and journal.
Total reproduction
It is expressly prohibited and must be authorized by the journal.
Abstract
Objective: To evaluate cognitive impairment in people who had COVID-19 infection. Methods: This is a cross-sectional observational study. It was conducted with 112 patients, over 18 years of age, of both genders, who had confirmed recovery from the disease through laboratory or clinical diagnosis proven by imaging methods. Participants were investigated for the presence of previous secondary comorbidities and risk factors. In addition, data from the physical examination and laboratory tests were collected and the Mini Mental State Examination (MMSE) was administered. Data were analyzed by Bioestat 5.0 and EpiInfo 7.0 software, using the G, Student’s T or Mann-Whitney tests and the D’Agostinho-Pearson normality test. Results: Patients with altered MMSE formed the case group 41,1% (n=46), the control group 58,9% (n=66) consisted of patients with no change in MMSE. When analyzing the data using a Simple Logistic Regression model, there was a difference between the case [n=26 (56%)] and control [n=32 (48%)] groups for the Metabolic Syndrome (MS) criteria OR=2.57, p=0.019, IC 95%= 1.167-5.68. Conclusion: The criteria for MS were shown to be a risk factor in the development of post-covid-19 Cognitive Deficit.
References
AHMED M, et al. Post-COVID-19 Memory Complaints: Prevalence and Associated Factors. Neurologia, 2022; 34(5): 2-6
BAIG AM e SANDERS EC. Potential neuroinvasive pathways of SARS-CoV-2: Deciphering the spectrum of neurological deficit seen in coronavirus disease-2019 (COVID-19). J Med Virol, 2020; 92(10): 1845-1857.
BAKER HA, et al. The 'third wave': impending cognitive and functional decline in COVID-19 survivors. Br J Anaesth, 2021;126 (1):44-47.
BEAUD V, et al. Pattern of cognitive deficits in severe COVID-19. J of Neurol, Neuros. & Psych., 2021; 92(5): 567-568.
BLAZHENETS G, et al. Slow but Evident Recovery from Neocortical Dysfunction and Cognitive Impairment in a Series of Chronic COVID-19 Patients. J Nucl Med, 2021;62(7): 910-915.
DAVIS H, et al. Long COVID: major findings, mechanisms and recommendations. Nat Rev Microbiol, 2023;(21):133–146.
DHAEZE T, et al. CD70 define um subconjunto de linfócitos TH 1/ TH 17 pró-inflamatórios e patogênicos do SNC e é superexpresso na esclerose múltipla. Cell Mol Immunol, 2019;16: 652-665.
GOËRTZ Y, et al. Persistent symptoms 3 months after a SARS‐CoV‐2 infection: the post‐COVID‐19 syndrome?. ERJ Open Res, 2020; 6 (4): 542.
HELMS J, et al. Neurologic features in severe SARS-CoV-2 infection. N. Engl. J. Med., 2020; 382: 2268– 2270.
HENEKA MT, et al. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther., 2020; 12 (1): 69.
HERRERA E, et al. Epidemiologic survey of dementia in a community-dwelling Brazilian population. Alzheimer Dis Assoc Disord., 2002;16: 103-108.
HOSP JA, et al. Cognitive impairment and altered cerebral glucose metabolism in the subacute stage of COVID-19. Brain, 2021; 144(4): 1263-1276.
HUGON j, et al. Long COVID: cognitive complaints (brain fog) and dysfunction of the cingulate cortex. J Neurol., 2022; 269(1): 44-46.
KRUGLIKOV IL e SCHERER PE. The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections. Obesity, 2020. 29(07):2-6.
MELO DM e BARBOSA AJG. O uso do Mini-Exame do Estado Mental em pesquisas com idosos no Brasil: uma revisão sistemática. Ciência & Saúde Coletiva, 2015; 20 (12): 3865-3876.
PEZZINI A e PADOVANI A. Lifting the mask on neurological manifestations of COVID-19. Nat Rev Neurol., 2020; 16 (11): 636-644.
EVANS RA, et al. Clinical characteristics with inflammation profiling of long COVID and association with 1-year recovery following hospitalisation in the UK: a prospective observational study. Lancet Respir Med., 2022; 10(8): 761-775.
SASANNEJAD C, et al. Long-term cognitive impairment after acute respiratory distress syndrome: a review of clinical impact and pathophysiological mechanisms. Crit Care, 2019; 23(1): 352.
VIEIRA EB, KOENING AM. Avaliação cognitiva. In: FREITAS, E.V. et al. Tratado de Geriatria e gerontologia. 2º ed. Rio de Janeiro: Guanabara Koogan, 2002; 921-928p.
WANG F, et al. Long-Term Respiratory and Neurological Sequelae of COVID-19. Med Sci Monit., 2020; 26: e928996.